Ranking vaccines . Phase III Use case studies and data framework : applications of a prioritization software tool / / Institute of Medicine and National Academy of Engineering of the National Academies

• Record Nr.: UNINA9910828846903321
• Pubbl/distr/stampa: Washington, District of Columbia : , : The National Academies Press, , 2015; ©2015
• ISBN: 0-309-30406-7; 0-309-30404-0
• Descrizione fisica: 1 online resource (128 p.)
• Disciplina: 615.19
• Soggetti: Drugs - Design; Vaccines - United States
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: ""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Disclaimer""; ""Summary""; ""1 Introduction: SMART Vaccines and Smart Priorities""; ""2 Data Synthesis and Framework""; ""3 Use Case Scenarios and Design Enhancements""; ""4 Reflections and Looking Forward""; ""References""; ""Appendix A: Use Case Scenarios Report for SMART Vaccines""; ""Appendix B: Committee's Response to the Use Case Scenarios Report""; ""Appendix C: SMART Vaccines Software Updates""; ""Appendix D: Stakeholder Speakers""; ""Appendix E: Biographical Information""
• Sommario/riassunto: "SMART Vaccines - Strategic Multi-Attribute Ranking Tool for Vaccines - is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I. The 2013 Phase II report refined a beta version of the model developed in the Phase I report. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework extends this project by demonstrating the practical applications of SMART Vaccines through ; use case scenarios in partnership with the Public Health Agency of Canada, New York State Department of Health, and the Serum Institute of India. This report also explores a novel application of SMART Vaccines in determining new vaccine product profiles, and offers practical strategies for data synthesis and estimation to encourage the broader use of the software." --